Ladarixin
- Generic Name
- Ladarixin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H12F3NO6S2
- CAS Number
- 849776-05-2
- Unique Ingredient Identifier
- DEH7Q6472O
- Background
Ladarixin is under investigation in clinical trial NCT04628481 (A Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual Β-Cell Function).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath